EcoDrugPlus

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSCCRG00000065546
Gene Symbol: GRM3
1 Cross references
209 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSCCRG00000025462
Gene Symbol: GRM5A
1 Cross references
208 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSCCRG00000015015
Gene Symbol: GRM5A
1 Cross references
209 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSCCRG00000024190
Gene Symbol: GRM5B
1 Cross references
218 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSCCRG00000041904
Gene Symbol: GRM5B
1 Cross references
219 Possible Orthologues:

Glutaminase

Ensembl ID : ENSCCRG00000070352
Gene Symbol: GLS
1 Cross references
171 Possible Orthologues:

Glutaminase

Ensembl ID : ENSCCRG00000071811
Gene Symbol: GLS
1 Cross references
171 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSCCRG00000062028
Gene Symbol: GLSA
1 Cross references
228 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSCCRG00000032031
Gene Symbol: GLSA
1 Cross references
227 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSCCRG00000059996
Gene Symbol: GSK3AA
1 Cross references
177 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSCCRG00000008932
Gene Symbol: GSK3AA
1 Cross references
177 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSCCRG00000056487
Gene Symbol: GSK3AB
1 Cross references
183 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).